United States Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032

United States Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A19074
Year End sale Buy Now

Market Overview:

The United States companion diagnostics market size reached US$ 2.17 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.41 Billion by 2032, exhibiting a growth rate (CAGR) of 10.70% during 2024-2032. The rising prevalence of chronic diseases, ongoing technological advancements in personalized medicine, and strong regulatory support across the country fostering significant growth in precision healthcare and targeted therapeutic approaches represent some of the key factors driving the market.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 2.17 Billion
Market Forecast in 2032
US$ 5.41 Billion
Market Growth Rate 2024-2032 10.70%


Companion diagnostics are medical devices, often assays or tests, designed to assist healthcare professionals in determining whether a particular treatment or therapeutic product is appropriate for a patient. They help evaluate the patient's biomarkers, genetic makeup, or other specific characteristics to ascertain the suitability and potential effectiveness of a specific drug therapy. The utilization of companion diagnostics is transformative in oncology and various other medical specialties, enabling more personalized treatment approaches. By identifying patients most likely to benefit from a particular treatment, these diagnostics enhance treatment efficacy and reduce the likelihood of adverse reactions. They also support drug development by identifying target patient populations, thereby streamlining clinical trials and aiding in the development of more targeted therapies. The integration of companion diagnostics in healthcare aligns with the evolving landscape of personalized medicine, where treatments are increasingly tailored to individual patient profiles. This approach improves patient outcomes and contributes to the greater efficiency and cost-effectiveness of healthcare systems. Presently, companion diagnostics are gaining prominence in the field of precision medicine, and its scope and application are expected to expand as research progresses, further revolutionizing patient care and treatment methodologies.

United States Companion Diagnostics Market Trends:

The United States companion diagnostics market is experiencing significant growth, driven by a confluence of factors that reflect both technological advancements and evolving healthcare paradigms. One of the primary drivers is the growing prevalence of chronic diseases, particularly cancer, where companion diagnostics play a crucial role in personalized treatment. This rise in chronic conditions necessitates more efficient and targeted therapeutic approaches, fueling the demand for companion diagnostics. Besides this, technological innovations, such as continuous advances in genomics and biotechnology, have enabled the development of more sophisticated companion diagnostics, offering precise insights into patient-specific disease mechanisms. This technological leap enhances the efficacy of personalized treatments, thereby accelerating the adoption of companion diagnostics. Additionally, the pharmaceutical industry's shift toward precision medicine represents a major growth-inducing factor as drug developers are increasingly focusing on creating targeted therapies, often in conjunction with companion diagnostics, to ensure optimal patient outcomes. This synergy between drug development and diagnostics is pivotal in propelling market growth. Furthermore, the increasing regulatory support from bodies like the FDA's endorsement and streamlined approval processes for companion diagnostics, especially those targeting unmet medical needs, is fostering innovation and investment in this sector. In line with this, the growing awareness among healthcare providers and patients about the benefits of personalized medicine is catalyzing the demand for companion diagnostics. As healthcare shifts toward value-based care, the focus on achieving better patient outcomes at lower costs aligns well with the capabilities of companion diagnostics. Moreover, the increasing collaborations and partnerships among diagnostic companies and pharmaceutical firms are leading to the development of more integrated and effective diagnostic solutions, overcoming technical and regulatory challenges and thereby supporting market growth. Along with this, the rising healthcare expenditure in the United States, coupled with favorable reimbursement policies for advanced diagnostic tests, has spurred the adoption of companion diagnostics, positively influencing market growth.

United States Companion Diagnostics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product & service, technology, indication, and end user.

Product & Service Insights:

United States Companion Diagnostics Market Report

  • Assays, Kits and Reagents
  • Software and Services
     

The report has provided a detailed breakup and analysis of the market based on the product & service. This includes assays, kits and reagents and software and services.

Technology Insights:

  • Immunohistochemistry (IHC)
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Real-time PCR (RT-PCR)
  • Gene Sequencing
  • Others
     

A detailed breakup and analysis of the market based on technology have also been provided in the report. This includes immunohistochemistry (IHC), polymerase chain reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), gene sequencing, and others.

Indication Insights:

  • Cancer
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Gastric Cancer
    • Melanoma
    • Others
  • Neurological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the indication. This includes cancer (lung cancer, breast cancer, colorectal cancer, gastric cancer, melanoma, and others), neurological diseases, infectious diseases, cardiovascular diseases, and others.

End User Insights:

  • Pharmaceutical & Biopharmaceutical Companies 
  • Reference Laboratories
  • Contract Research Organizations
  • Others
     

A detailed breakup and analysis of the market based on end users have also been provided in the report. This includes pharmaceutical & biopharmaceutical companies, reference laboratories, contract research organizations, and others.

Regional Insights:

United States Companion Diagnostics Market Report

  • Northeast
  • Midwest
  • South
  • West
     

The report has also provided a comprehensive analysis of all the major regional markets, which include the Northeast, Midwest, South, and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States Companion Diagnostics Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Product & Service
  • Technology
  • Indication
  • End User
  • Region
Product & Services Covered Assays, Kits and Reagents, Software and Services
Technologies Covered Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, Others
Indications Covered
  • Cancer: Lung Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, Others
  • Neurological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others
End Users Covered Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others
Regions Covered Northeast, Midwest, South, West
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the United States companion diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the United States companion diagnostics market?
  • What is the breakup of the United States companion diagnostics market on the basis of product & service?
  • What is the breakup of the United States companion diagnostics market on the basis of technology?
  • What is the breakup of the United States companion diagnostics market on the basis of indication?
  • What is the breakup of the United States companion diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the United States companion diagnostics market?
  • What are the key driving factors and challenges in the United States companion diagnostics?
  • What is the structure of the United States companion diagnostics market and who are the key players?
  • What is the degree of competition in the United States companion diagnostics market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States companion diagnostics market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the United States companion diagnostics market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States companion diagnostics industry and its attractiveness.
  • A competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
United States Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032
Purchase Options Year End sale




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARATI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More
DEinternational Egypt

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

Read More
Gulf Excellent Group

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Read More
FS Corporation Inc.

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

Read More
Egyptian Industrial Investment Group

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

Read More
Vishnu Chemicals

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

Read More
MOUNT EVEREST BREWERIES LIMITED

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

Read More
Borges Branded Foods

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

Read More
Godrej Consumer Products Limited

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

Read More
ADC Therapeutics

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

Read More
Ivanti

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

Read More
Asiatic Electrical & Switchgear P. Ltd.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Read More
Denka Co., Ltd.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.

Read More